Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Islet Allotransplantation for Type 1 Diabetic Patients

NCT03259256 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT03259256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03259256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Islet Allotransplantation for Type 1 Diabetic Patients
Lead sponsor
Second Affiliated Hospital of Guangzhou Medical University
Phase
Phase 3
Overall status
Unknown status
Start date
April 23, 2017
Completion date
June 30, 2019
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetic